Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis
Karla Solo(Western University), Rodrigo Bagur, A. Huitema(Western University), Glenn N. Levine(American College of Cardiology), Nikolaos Tzemos(Western University), Janet Martin, Mamas A. Mamas(University Hospitals of North Midlands NHS Trust), Conrad Kabali(University of Toronto), Marc Ruel(University of Ottawa), Alexander Kulik(Boca Raton Regional Hospital), Tawfiq Choudhury(University of Liverpool), Shahar Lavi(London Health Sciences Centre), Ava John‐Baptiste(Western University), John W. Eikelboom(Population Health Research Institute), Stephen E. Fremes(Institute of Health Services and Policy Research), Deepak L. Bhatt(Mount Sinai Hospital)
Cited by 106
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k